With the aim of optimizing Drug Eluting Stents (DES), particular attention has been laid on computational methods of controlling the drug release profile among researchers. Consequently, various models and simulations are available in the literature. Nevertheless, validations based on biorelevant in-vitro trials are lacking. In the present study, a comparison of drug release from polyurethane samples between calculated results and experimental-data has been carried out. The calculation results are from a numerical simulation and a newly established mathematical model for reproducing the liberation kinetic. Different fluid flow rates and initial drug concentrations in polymer have been taken into account
In this study, we consider a family of mathematical models to describe the elution of drug from poly...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
A two dimensional coupled nonlinear non-Fickian model for drug release from a biodegradable drug elu...
With the aim of optimizing Drug Eluting Stents (DES), particular attention has been laid on computat...
International audienceIn this study, we present a method for prediction of the drug-release profile ...
Drug-eluting stents have significantly improved the treatment of coronary artery disease. They offer...
Traditional coronary drug-eluting stents (DES) are made from metal and are coated with a permanent p...
Drug-eluting implants with a polymeric matrix are currently widely used and the interest of modeling...
Drug-eluting stents implanted in blood vessels are subject to various dynamics of blood flow. In thi...
In this paper we describe a combined in-vitro experimental and mathematical modelling approach to p...
In this paper we describe a combined in-vitro experimental and mathematical modelling approach to pr...
Medicated cardiovascular stents, also called drug eluting stents (DES), represent a relevant applica...
In this study, we consider a family of mathematical models to describe the elution of drug from poly...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
A two dimensional coupled nonlinear non-Fickian model for drug release from a biodegradable drug elu...
With the aim of optimizing Drug Eluting Stents (DES), particular attention has been laid on computat...
International audienceIn this study, we present a method for prediction of the drug-release profile ...
Drug-eluting stents have significantly improved the treatment of coronary artery disease. They offer...
Traditional coronary drug-eluting stents (DES) are made from metal and are coated with a permanent p...
Drug-eluting implants with a polymeric matrix are currently widely used and the interest of modeling...
Drug-eluting stents implanted in blood vessels are subject to various dynamics of blood flow. In thi...
In this paper we describe a combined in-vitro experimental and mathematical modelling approach to p...
In this paper we describe a combined in-vitro experimental and mathematical modelling approach to pr...
Medicated cardiovascular stents, also called drug eluting stents (DES), represent a relevant applica...
In this study, we consider a family of mathematical models to describe the elution of drug from poly...
Drug-eluting stents have been used widely to prevent restenosis of arteries following percutaneous b...
A two dimensional coupled nonlinear non-Fickian model for drug release from a biodegradable drug elu...